Exact Mass: 517.2114
Exact Mass Matches: 517.2114
Found 500 metabolites which its exact mass value is equals to given mass value 517.2114
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pyronaridine
Pyronaridine belongs to the family of Naphthyridines. These are compounds containing a naphthyridine moeity, a naphthalene in which a carbon atom has been replaced by a nitrogen in each of the two rings. The naphthyridine skeleton can also be described as an assembly two fused pyridine rings, which do not share their nitrogen atom.
Propafenone glucuronide
3-(5-(4-(Cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxybenzo[d]isoxazol-6-yl)methoxy)phenyl)propanoic acid
5-des-O-methylisoharringtonine|isoharringtonic acid
(3aS)-5c-[(1R,2E,4E)-6-hydroxy-1,3-dimethyl-6-((E)-1-methyl-2,4-dioxo-pyrrolidin-3-ylidene)-hexa-2,4-dienyl]-2c,6t,9a-trimethyl-8-oxo-(9at)-octahydro-3ar,7c-epioxido-furo[3,2-b]oxocine-3c-carboxylic acid methyl ester|antibiotic Bu-2313-A|N-methyl-nocamycin-I
Lys Asn Gln Glu
Arg Asp Val Glu
Arg Ile Asp Asp
Asn Lys Gln Glu
Ala His Gln Tyr
Ala His Tyr Gln
Ala Asn Gln Trp
Ala Asn Trp Gln
Ala Gln His Tyr
Ala Gln Asn Trp
Ala Gln Trp Asn
Ala Gln Tyr His
Ala Trp Asn Gln
Ala Trp Gln Asn
Ala Tyr His Gln
Ala Tyr Gln His
Cys Cys His Arg
Cys Cys Arg His
Cys His Cys Arg
Cys His Lys Met
Cys His Met Lys
Cys His Met Gln
Cys His Gln Met
Cys His Arg Cys
Cys Ile Pro Trp
Cys Ile Trp Pro
Cys Lys His Met
Cys Lys Met His
Cys Leu Pro Trp
Cys Leu Trp Pro
Cys Met His Lys
Cys Met His Gln
Cys Met Lys His
Cys Met Gln His
Cys Pro Ile Trp
Cys Pro Leu Trp
Cys Pro Trp Ile
Cys Pro Trp Leu
Cys Gln His Met
Cys Gln Met His
Cys Arg Cys His
Cys Arg His Cys
Cys Trp Ile Pro
Cys Trp Leu Pro
Cys Trp Pro Ile
Cys Trp Pro Leu
Asp Asp Ile Arg
Asp Asp Leu Arg
Asp Asp Arg Ile
Asp Asp Arg Leu
Asp Glu Arg Val
Asp Glu Val Arg
Asp Ile Asp Arg
Asp Ile Arg Asp
Asp Lys Gln Gln
Asp Leu Asp Arg
Asp Leu Arg Asp
Asp Met Pro Arg
Asp Met Arg Pro
Asp Asn Asn Arg
Asp Asn Arg Asn
Asp Pro Met Arg
Asp Pro Arg Met
Asp Pro Thr Trp
Asp Pro Trp Thr
Asp Gln Lys Gln
Asp Gln Gln Lys
Asp Gln Gln Gln
Asp Arg Asp Ile
Asp Arg Asp Leu
Asp Arg Glu Val
Asp Arg Ile Asp
Asp Arg Leu Asp
Asp Arg Met Pro
Asp Arg Asn Asn
Asp Arg Pro Met
Asp Arg Val Glu
Asp Thr Pro Trp
Asp Thr Trp Pro
Asp Val Glu Arg
Asp Val Arg Glu
Asp Trp Pro Thr
Asp Trp Thr Pro
Glu Asp Arg Val
Glu Asp Val Arg
Glu Glu Ile Gln
Glu Glu Leu Gln
Glu Glu Gln Ile
Glu Glu Gln Leu
Glu Ile Glu Gln
Glu Ile Gln Glu
Glu Lys Asn Gln
Glu Lys Gln Asn
Glu Leu Glu Gln
Glu Leu Gln Glu
Glu Asn Lys Gln
Glu Asn Gln Lys
Glu Asn Gln Gln
Glu Pro Ser Trp
Glu Pro Trp Ser
Glu Gln Glu Ile
Glu Gln Glu Leu
Glu Gln Ile Glu
Glu Gln Lys Asn
Glu Gln Leu Glu
Glu Gln Asn Gln
Glu Gln Gln Asn
Glu Ser Pro Trp
Glu Ser Trp Pro
Glu Trp Pro Ser
Glu Trp Ser Pro
Phe His Asn Thr
Phe His Gln Ser
Phe His Ser Gln
Phe His Thr Asn
Phe Asn His Thr
Phe Asn Thr His
Phe Gln His Ser
Phe Gln Ser His
Phe Ser His Gln
Phe Ser Gln His
Phe Thr His Asn
Phe Thr Asn His
Naltrexone-3-glucuronide
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids
Gly Gln Gln Trp
Gly Gln Trp Gln
Gly Trp Gln Gln
His Ala Gln Tyr
His Ala Tyr Gln
His Cys Cys Arg
His Cys Lys Met
His Cys Met Lys
His Cys Met Gln
His Cys Gln Met
His Cys Arg Cys
His Phe Asn Thr
His Phe Gln Ser
His Phe Ser Gln
His Phe Thr Asn
His His Pro Gln
His His Gln Pro
His Lys Cys Met
His Lys Met Cys
His Met Cys Lys
His Met Cys Gln
His Met Lys Cys
His Met Gln Cys
His Asn Phe Thr
His Asn Thr Phe
His Pro His Gln
His Pro Gln His
His Gln Ala Tyr
His Gln Cys Met
His Gln Phe Ser
His Gln His Pro
His Gln Met Cys
His Gln Pro His
His Gln Ser Phe
His Gln Tyr Ala
His Arg Cys Cys
His Ser Phe Gln
His Ser Gln Phe
His Thr Phe Asn
His Thr Asn Phe
His Tyr Ala Gln
His Tyr Gln Ala
Ile Cys Pro Trp
Ile Cys Trp Pro
Ile Glu Glu Gln
Ile Glu Gln Glu
Ile Pro Cys Trp
Ile Pro Trp Cys
Ile Gln Glu Glu
Ile Trp Cys Pro
Ile Trp Pro Cys
Lys Cys His Met
Lys Cys Met His
Lys His Cys Met
Lys His Met Cys
Lys Met Cys His
Lys Met His Cys
Leu Cys Pro Trp
Leu Cys Trp Pro
Leu Glu Glu Gln
Leu Glu Gln Glu
Leu Pro Cys Trp
Leu Pro Trp Cys
Leu Gln Glu Glu
Leu Trp Cys Pro
Leu Trp Pro Cys
Met Cys His Lys
Met Cys His Gln
Met Cys Lys His
Met Cys Gln His
Met Asp Pro Arg
Met Asp Arg Pro
Met His Cys Lys
Met His Cys Gln
Met His Lys Cys
Met His Gln Cys
Met Lys Cys His
Met Lys His Cys
Met Pro Asp Arg
Met Pro Arg Asp
Met Gln Cys His
Met Gln His Cys
Met Arg Asp Pro
Met Arg Pro Asp
Asn Ala Gln Trp
Asn Ala Trp Gln
Asn Asp Asn Arg
Asn Asp Arg Asn
Asn Glu Gln Gln
Asn Phe His Thr
Asn Phe Thr His
Asn His Phe Thr
Asn His Thr Phe
Asn Asn Asp Arg
Asn Asn Arg Asp
Asn Gln Ala Trp
Asn Gln Glu Gln
Asn Gln Gln Glu
Asn Gln Trp Ala
Asn Arg Asp Asn
Asn Arg Asn Asp
Asn Thr Phe His
Asn Thr His Phe
Asn Trp Ala Gln
Asn Trp Gln Ala
Pro Cys Ile Trp
Pro Cys Leu Trp
Pro Cys Trp Ile
Pro Cys Trp Leu
Pro Asp Met Arg
Pro Asp Arg Met
Pro Asp Thr Trp
Pro Asp Trp Thr
Pro Glu Ser Trp
Pro Glu Trp Ser
Pro His His Gln
Pro His Gln His
Pro Ile Cys Trp
Pro Ile Trp Cys
Pro Leu Cys Trp
Pro Leu Trp Cys
Pro Met Asp Arg
Pro Met Arg Asp
Pro Gln His His
Pro Arg Asp Met
Pro Arg Met Asp
Pro Ser Glu Trp
Pro Ser Trp Glu
Pro Thr Asp Trp
Pro Thr Trp Asp
Pro Trp Cys Ile
Pro Trp Cys Leu
Pro Trp Asp Thr
Pro Trp Glu Ser
Pro Trp Ile Cys
Pro Trp Leu Cys
Pro Trp Ser Glu
Pro Trp Thr Asp
Gln Ala His Tyr
Gln Ala Asn Trp
Gln Ala Trp Asn
Gln Ala Tyr His
Gln Cys His Met
Gln Cys Met His
Gln Asp Gln Gln
Gln Glu Glu Ile
Gln Glu Glu Leu
Gln Glu Ile Glu
Gln Glu Leu Glu
Gln Glu Asn Gln
Gln Glu Gln Asn
Gln Phe His Ser
Gln Phe Ser His
Gln Gly Gln Trp
Gln Gly Trp Gln
Gln His Ala Tyr
Gln His Cys Met
Gln His Phe Ser
Gln His His Pro
Gln His Met Cys
Gln His Pro His
Gln His Ser Phe
Gln His Tyr Ala
Gln Ile Glu Glu
Gln Leu Glu Glu
Gln Met Cys His
Gln Met His Cys
Gln Asn Ala Trp
Gln Asn Glu Gln
Gln Asn Gln Glu
Gln Asn Trp Ala
Gln Pro His His
Gln Gln Asp Gln
Gln Gln Glu Asn
Gln Gln Gly Trp
Gln Gln Asn Glu
Gln Gln Gln Asp
Gln Gln Trp Gly
Gln Ser Phe His
Gln Ser His Phe
Gln Trp Ala Asn
Gln Trp Gly Gln
Gln Trp Asn Ala
Gln Trp Gln Gly
Gln Tyr Ala His
Gln Tyr His Ala
Arg Cys Cys His
Arg Cys His Cys
Arg Asp Met Pro
Arg Asp Asn Asn
Arg Asp Pro Met
Arg His Cys Cys
Arg Met Asp Pro
Arg Met Pro Asp
Arg Asn Asp Asn
Arg Asn Asn Asp
Arg Pro Asp Met
Arg Pro Met Asp
Ser Glu Pro Trp
Ser Glu Trp Pro
Ser Phe His Gln
Ser Phe Gln His
Ser His Phe Gln
Ser His Gln Phe
Ser Pro Glu Trp
Ser Pro Trp Glu
Ser Gln Phe His
Ser Gln His Phe
Ser Trp Glu Pro
Ser Trp Pro Glu
Thr Asp Pro Trp
Thr Asp Trp Pro
Thr Phe His Asn
Thr Phe Asn His
Thr His Phe Asn
Thr His Asn Phe
Thr Asn Phe His
Thr Asn His Phe
Thr Pro Asp Trp
Thr Pro Trp Asp
Thr Trp Asp Pro
Thr Trp Pro Asp
Trp Ala Asn Gln
Trp Ala Gln Asn
Trp Cys Ile Pro
Trp Cys Leu Pro
Trp Cys Pro Ile
Trp Cys Pro Leu
Trp Asp Pro Thr
Trp Asp Thr Pro
Trp Glu Pro Ser
Trp Glu Ser Pro
Trp Gly Gln Gln
Trp Ile Cys Pro
Trp Ile Pro Cys
Trp Leu Cys Pro
Trp Leu Pro Cys
Trp Asn Ala Gln
Trp Asn Gln Ala
Trp Pro Cys Ile
Trp Pro Cys Leu
Trp Pro Asp Thr
Trp Pro Glu Ser
Trp Pro Ile Cys
Trp Pro Leu Cys
Trp Pro Ser Glu
Trp Pro Thr Asp
Trp Gln Ala Asn
Trp Gln Gly Gln
Trp Gln Asn Ala
Trp Gln Gln Gly
Trp Ser Glu Pro
Trp Ser Pro Glu
Trp Thr Asp Pro
Trp Thr Pro Asp
Tyr Ala His Gln
Tyr Ala Gln His
Tyr His Ala Gln
Tyr His Gln Ala
Tyr Gln Ala His
Tyr Gln His Ala
Pyronaridine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
2-Methyl-2-propanyl 4-(6-{[5-bromo-4-(cyclopentylamino)-2-pyrimid inyl]amino}-3-pyridinyl)-1-piperazinecarboxylate
Fmoc-4-(tert-butoxycarbonylmethoxy)-L-phenylalanine
Stallimycin hydrochloride
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D004214 - Distamycins D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
3-(5-(4-(Cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxybenzo[d]isoxazol-6-yl)methoxy)phenyl)propanoic acid
1-[2-(3,4-dimethoxyphenyl)ethyl]-2-imino-10-methyl-5-oxo-N-(2-oxolanylmethyl)-3-dipyrido[3,4-c:1,2-f]pyrimidinecarboxamide
N(5)-[amino(sulfoamino)phosphoryl]-L-ornithyl-L-alanyl-L-arginine
(2S)-2-[[(2S)-2-[[(2S)-5-[[amino-(sulfonatoamino)phosphoryl]amino]-2-azaniumylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneazaniumyl)pentanoate
(2R)-2-[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[[(2-fluorophenyl)methyl-methylamino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
[(1S,2S)-cyclohexane-1,2-diamine-kappa(2)N,N](5,6-dimethyl-1,10-phenanthroline-kappa(2)N(1),N(10))platinum(2+)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
[(1R)-7-methoxy-2-(4-methylphenyl)sulfonyl-1-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-3-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
1-[(2R,3S)-4-[(2,5-difluorophenyl)methyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2R,3R)-4-[(2,5-difluorophenyl)methyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]-3-[4-(trifluoromethyl)phenyl]urea
(3R)-N-benzyl-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-[3-[(E)-prop-1-enyl]phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-2-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-3-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-3-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
(3S)-N-benzyl-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-[3-[(E)-prop-1-enyl]phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
N-[[(2R,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3S)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3R)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3R)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
(2S)-2-[(4S,5S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[[(2-fluorophenyl)methyl-methylamino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[[(2-fluorophenyl)methyl-methylamino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
1-[(2R,3S)-4-[(2,5-difluorophenyl)methyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]-3-[4-(trifluoromethyl)phenyl]urea
[(1R)-7-methoxy-1-(4-methylphenyl)sulfonyl-2-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
N-[[(2S,3S)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2S,3R)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
N-[[(2R,3R)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
(2S)-2-[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[[(2-fluorophenyl)methyl-methylamino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[[(2-fluorophenyl)methyl-methylamino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
1-[(2S,3R)-4-[(2,5-difluorophenyl)methyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2R,3R)-4-[(2,5-difluorophenyl)methyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2S,3S)-4-[(2,5-difluorophenyl)methyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2S,3R)-4-[(2,5-difluorophenyl)methyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]-3-[4-(trifluoromethyl)phenyl]urea
[(1S)-7-methoxy-2-(4-methylphenyl)sulfonyl-1-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
[(1S)-7-methoxy-1-(4-methylphenyl)sulfonyl-2-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
(2E)-3-ethyl-2-[(E)-3-(3-ethyl-4,5-diphenyl-1,3-thiazol-3-ium-2-yl)prop-2-enylidene]benzo[g][1,3]benzothiazole
2-amino-3-[hydroxy-[2-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]phosphoryl]oxypropanoic acid
Phaseolotoxin
A tripeptide resulting from the formal condensation of the carboxy group of N(5)-[amino(sulfoamino)phosphoryl]-L-ornithine with the N-terminal amino group of L-alanyl-L-arginine. A toxin produced by cultured Pseudomonas syringae, the causal agent of halo blight disease in bean plants.
AZD3147
AZD3147 is a potent, orally active, selective dual inhibitor of mTORC1 and mTORC2 with an IC50 value of 1.5 nM. AZD3147 also has a selective effect on PI3K[1]. AZD3147 is a potent, orally active, selective dual inhibitor of mTORC1 and mTORC2 with an IC50 value of 1.5 nM. AZD3147 also has a selective effect on PI3K[1].